Predicting 28-Day Mortality in Subarachnoid Hemorrhage
NCT06563219 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 451
Last updated 2024-08-20
Summary
The investigators investigated the predictive ability of clinical and radiological scores, including the Glasgow coma scale (GCS), Hunt-Hess, World Federation of Neurological Surgeons (WFNS), and modified Fisher scales, as well as combined clinical scores such as the VASOGRADE and Ogilvy-Carter rating scales, for 28-day mortality in patients presenting to the emergency department (ED) with non-traumatic subarachnoid hemorrhage (SAH). Specifically, we tested the hypothesis that combined clinical scores are more reliable and superior to non-combined clinical and radiological scores in predicting 28-day mortality in non-traumatic SAH.
Conditions
- Subarachnoid Hemorrhage, Aneurysmal
Interventions
- OTHER
-
Glasgow coma scale
The levels of response in the components of the Glasgow Coma Scale are 'scored' from 1, for no response, up to normal values of 4 (Eye-opening response) 5 ( Verbal response) and 6 (Motor response) The total Coma Score thus has values between three and 15, three being the worst and 15 being the highest.
- OTHER
-
Hunt-Hess scale
The Hunt-Hess scale was used to assess SAH severity according to the clinical presentation and the visible neurological deficits. The Grades run from 1 to 5: * Grade 1: Asymptomatic or minimal headache, slight neck stiffness. * Grade 2: Moderate to severe headache, and neck stiffness, but no neurological deficit except cranial nerve palsy. * Grade 3: Drowsiness, confusion, or a mild focal deficit. * Grade 4: Stupor, moderate to severe hemiparesis, early decerebrate rigidity, and vegetative disturbance. * Grade 5: Deep coma, decerebrate rigidity, and a moribund appearance.
- OTHER
-
World Federation of Neurological Surgeons (WFNS) scale
The World Federation of Neurological Surgeons (WFNS) scale, introduced in 1988, is used to evaluate the clinical severity of patients with SAH. This scale is derived from the GCS score and considers the presence of motor deficits: * Grade 1: GCS score of 15, no motor deficit * Grade 2: GCS score of 13 to 14, no motor deficit * Grade 3: GCS score of 13 to 14, with motor deficit * Grade 4: GCS score of 7 to 12, with or without motor deficit * Grade 5: GCS score of 3 to 6, with or without motor deficit
- OTHER
-
modified Fisher scale
The modified Fisher scale was used to evaluate SAH severity by reference to the extent of hemorrhage as revealed by CT of the brain. Four grades are depending on the degree of bleeding observed: * Grade 0: No hemorrhage apparent in CT. * Grade 1: Minimal hemorrhage without intraventricular hemorrhage (IVH). * Grade 2: Thin or diffusely thin (\<1mm) hemorrhage with bilateral IVH. * Grade 3: Thick (\> 1 mm) hemorrhage without bilateral IVH. * Grade 4: Thick (\> 1 mm) hemorrhage with bilateral IVH.
- OTHER
-
VASOGRADE scale
The VASOGRADE scale was established to estimate the risk of delayed cerebral ischemia following SAH. This scale is based on the WFNS and the modified Fisher scales at admission. There are three categories: * Green: WFNS score of 1 or 2 and modified Fisher scale of 1 or 2. * Yellow: WFNS score of 1 or 3 and modified Fisher scale of 3 or 4. * Red: WFNS score of 4 or 5 and any modified Fisher scale score.
- OTHER
-
Ogilvy and Carter scale
The Ogilvy and Carter scale is a grading system used to predict the outcomes of surgical treatment in patients with SAH due to a ruptured aneurysm. The scale considers multiple factors, including age, Hunt and Hess grade, Fisher grade, and aneurysm size, with a score assigned to each of these variables: * Age greater than 50 * Hunt and Hess grade of 4 to 5 * Fisher grade scores of 3 to 4 * Aneurysm size \>10 mm * An additional point is added for a giant posterior circulation aneurysm (≥25 mm)
Sponsors & Collaborators
-
Haseki Training and Research Hospital
lead OTHER
Principal Investigators
-
Adem Az, M.D. · Haseki Training and Research Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2023-09-01
- Completion
- 2024-08-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Cerebrospinal Fluid Hemoglobin to Monitor for Aneurysmal Subarachnoid Hemorrhage Related Secondary Brain Injury
NCT04998370 ·Status: COMPLETED
-
Neurological Outcome in Patients of Traumatic Subarachnoid Haemorrhage
NCT02073890 ·Status: COMPLETED
-
Constitution of Cerebrospinal Fluid and Blood Database/Specimen in Acute Stage of Subarachnoid Hemorrhage (aSAH) Patients
NCT01292278 ·Status: UNKNOWN
-
Predictive Model for the Occurrence of Cerebral Vasospasm Complicating Subarachnoid Haemorrhage by Combined Analysis of the Kinetics of a Panel of Biomarkers.
NCT06303349 ·Status: COMPLETED ·Phase: NA
-
Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital
NCT06560372 ·Status: RECRUITING ·Phase: NA
-
Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage
NCT00968227 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Role of Meningeal Lymphatic Vessels in the Absorption of Chronic Subdural Hematoma and Its Injury Mechanism
NCT05426889 ·Status: UNKNOWN ·Phase: NA
-
Searching a Dysfunction of Corticotropic & Thyrotropin Axis During the Acute Phase of a Subarachnoid Hemorrhage Secondary to Spontaneous Rupture of Cerebral Aneurysm
NCT03655509 ·Status: UNKNOWN ·Phase: NA
-
Degradation of the Glycocalyx in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage
NCT03706768 ·Status: UNKNOWN ·Phase: NA
-
Shunt-dependency After aSAH - Role of Early Hyperglycaemia in CSF and Blood
NCT06486909 ·Status: RECRUITING
-
Superior Cervical Sympathetic Block Versus Stellate Ganglion Block in Post-traumatic Subarachnoid Hemorrhage
NCT06134583 ·Status: COMPLETED ·Phase: NA
-
Predictive Value of Mean Flow Velocity by TCD in Early Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage
NCT04329208 ·Status: COMPLETED
-
Hypothalamo-, Pituitary-, Adrenal Axis Dysfunction in Subarachnoid Hemorrhage
NCT00614887 ·Status: COMPLETED
-
Permanent Cerebral Oxymetry Monitoring for Early Diagnosis and Treatment of Delayed Vasospasm After Subarachnoid Hemorrhage
NCT04042571 ·Status: COMPLETED ·Phase: NA
-
NIRS Directed Optimal Cerebral Perfusion Pressure in Aneurysmal Subarachnoid Hemorrhage Patients: A Feasibility Study
NCT03879330 ·Status: UNKNOWN
-
Urea Therapy for Hyponatremia in Subarachnoid Hemorrhage
NCT04552873 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Aneurysmal Subarachnoid Hemorrhage and Superior Mesenteric Artery Flow Study
NCT02684500 ·Status: COMPLETED
-
Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients
NCT06265259 ·Status: RECRUITING ·Phase: PHASE4
-
Metabolomic Profile and Proteasic Activity as Biomarkers for Early Detection of Arterial Vasospas in Arterial Vasospasm After Aneurysmal Subarachnoid Hemorrhage
NCT02397759 ·Status: UNKNOWN ·Phase: NA
-
Trial of Long-term Therapeutic Hypothermia for Poor-grade Aneurysmal Subarachnoid Hemorrhage
NCT03442608 ·Status: UNKNOWN ·Phase: NA
-
Continuous Assessment of Brain Blood Perfusion in Subarachnoid Hemorrhage Patients Using Near-Infrared Spectroscopy (NIRS)
NCT06932640 ·Status: NOT_YET_RECRUITING
-
Contrast Enhanced Ultrasound Imaging for Cerebral Perfusion Measurement in Cerebral Vasospasm After SAH
NCT02907879 ·Status: TERMINATED
-
Determinants of Vasospasm and Delayed Ischemic Deficits in Aneurysmal Subarachnoid Hemorrhage
NCT02829398 ·Status: COMPLETED ·Phase: NA
-
Correlation of Measured and Calculated Serum Osmolality During Hyperosmolar Drugs Infusion in Patients After Craniotomy
NCT02037815 ·Status: COMPLETED ·Phase: PHASE4
-
Normothermia in Patients With Acute Cerebral Damage
NCT00491192 ·Status: UNKNOWN ·Phase: PHASE4